title: Bacteremia caused by an Acinetobacter junii strain harboring class 1 integron and diverse DNA mobile elements.
abstract: BACKGROUND
  Infections caused by Acinetobacter junii are rarely reported. However, some outbreaks of septicemia in neonates and pediatric oncology patients, as well as meningitis, peritonitis, and ocular infection have been described. Since it is highly infrequent to find the molecular characterization of A. junii strains in literature, in this study we described the molecular characterization of A. junii isolates recovered from blood samples of a renal transplant patient.
  
  
  METHODS
  The case was defined as a catheter-related bacteremia caused by A. junii. The patient responded favorably after catheter removal and treatment with ciprofloxacin.
  
  
  CONCLUSIONS
  The complete molecular characterization of the isolate showed that it harbored a class 1 integron and diverse DNA mobile elements. This explains its genomic plasticity for acquiring antimicrobial resistance determinants and for adapting to a nosocomial niche.
authors.affiliation: Facultad de Medicina, Universidad de Buenos Aires, Argentina. gertra13a@gmail.com.
authors.forename: German Matías
authors.initials: GM
authors.lastname: Traglia
authors.forename: Marisa
authors.initials: M
authors.lastname: Almuzara
authors.forename: Elisabet
authors.initials: E
authors.lastname: Vilacoba
authors.forename: Alicia
authors.initials: A
authors.lastname: Tuduri
authors.forename: Gabriela
authors.initials: G
authors.lastname: Neumann
authors.forename: Elida
authors.initials: E
authors.lastname: Pallone
authors.forename: Daniela
authors.initials: D
authors.lastname: Centrón
authors.forename: Maria Soledad
authors.initials: MS
authors.lastname: Ramírez
mesh_terms: D000150:Acinetobacter / Q000235:genetics* / Q000302:isolation & purification; D000151:Acinetobacter Infections / Q000188:drug therapy / Q000382:microbiology*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology*; D055499:Catheter-Related Infections / Q000188:drug therapy / Q000382:microbiology; D002939:Ciprofloxacin / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000235:genetics*; D005260:Female; D006801:Humans; D032023:Integrons; D020071:Interspersed Repetitive Sequences; D016030:Kidney Transplantation; D066027:Transplant Recipients; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D002939:Ciprofloxacin